Form 4: AtriCure CTO Salvatore Privitera Increases Stake Through Employee Stock Purchase Plan

AtriCure, Inc.'s Chief Technical Officer, Salvatore Privitera, acquired 822 shares of common stock at a discounted price of $25.84 per share through the company's Employee Stock Purchase Plan.

Summary

• Salvatore Privitera, Chief Technical Officer of AtriCure, Inc. (ATRC), acquired 822 shares of common stock.
• The acquisition occurred on June 30, 2025.
• Shares were purchased at a price of $25.84 per share.
• The purchase was made through the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP).
• The purchase price represents 85% of the closing price on January 2, 2025, which was $30.40, the first trading day of the offering period.
• Following this transaction, Salvatore Privitera beneficially owns 125,587 shares of AtriCure, Inc. common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even through an ESPP, generally indicates confidence in the company's future performance. While not a direct open-market purchase, it still reflects a positive commitment to the company's stock.

Positives

• An insider, the Chief Technical Officer, is increasing their stake in the company, which can signal confidence in future performance.
• The acquisition was made through an Employee Stock Purchase Plan (ESPP), indicating participation in a broad-based employee benefit program.

Negatives

• No direct negatives are indicated in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

Insider purchases, even through employee plans, can be viewed as a positive signal of management's belief in the company's prospects within the medical device industry. This type of transaction is a routine part of employee compensation and ownership programs.

Comparison to Industry Standards

• This transaction is a standard acquisition through an Employee Stock Purchase Plan (ESPP), which is a common benefit offered by publicly traded companies across various industries, including medical devices.
• The discount offered (15% off the initial offering period price) is typical for such plans, designed to encourage employee ownership.
• No specific comparable companies or projects are mentioned in the filing.

Related Party Transactions

• No related party dealings are disclosed beyond the standard Employee Stock Purchase Plan participation.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be perceived positively, signaling management's belief in the company's value and potentially boosting investor confidence.
• Employees: The transaction highlights the availability and utilization of the Employee Stock Purchase Plan, which is a benefit for employees to acquire company stock at a discount.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Recommendation

Keywords

AtriCure, ATRC, Salvatore Privitera, Chief Technical Officer, Insider Trading, SEC Form 4, Stock Purchase, Employee Stock Purchase Plan, ESPP, Medical Devices